News » Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery

News by date

Powered by mod LCA

Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery

Wednesday, 05 March 2014 00:00 Written by Administrator

Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery

Viva Biotech Ltd., a leading company in structure-based and fragment based drug discovery services, based in Shanghai, China, and HQL Pharmaceuticals Ltd., a drug discovery company utilizing its super-power proprietary ChemSpace Scanner (CSS™) computational technology, based in Rehovot, Israel, today announced that they have entered into a strategic alliance to jointly provide a fully-integrated drug discovery services, focused on leads generation based on fragment screening.

[read the article]